Regulatory roundup for nutraceuticals: news from the US and Europe

By Emily Letton | Published: 10-Mar-2026
Regulatory

From fresh guidance on the FDA's Food Traceability Rule, to EFSA’s rapid outbreak assessment on cereulide in infant formula and rising antimicrobial resistance, regulators in the US and EU have issued key updates with implications for the nutraceutical supply chain

You need to be a subscriber to read this article.
Click here to find out more.

Last month, the US Food and Drug Administration (FDA), the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC) made several announcements about regulatory changes.

Nutraceutical Business Review looks at the most recent changes in F&B and supplement rules. 

FDA takes several actions regarding the Food Traceability Rule

In the US, the FDA issued guidance addressing stakeholder questions regarding the implementation of the Food Traceability Rule in mid-February.

The Food Traceability Rule establishes additional record-keeping requirements for manufacturers, processors, packers and holders of foods on the FDA's Food Traceability List.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.

Subscribe now Already a subscriber? Sign in here.
  • Companies:
  • US Food and Drug Administration (FDA)
  • Danone
  • EFSA
See more

You may also like

Regulatory

FDA calls public meeting to explore scope of dietary supplement ingredients under DSHEA

Read more
The FDA has announced a public meeting on 27 March to gather stakeholder feedback on the definition of dietary ingredient categories, including proteins, enzymes and microbials, as it considers its next regulatory steps

Trending Articles

  1. The NAD⁺ liposome problem: supplement science vs marketing claims New analysis raises questions about quality, formulation, and verification of liposomal NAD⁺ products
  2. dsm-firmenich strengthens HMO offering in Asia with new regulatory approvals The company continues its regulatory success in Asia’s early life nutrition market with approval of four new HMOs in Malaysia and Thailand, alongside commercial authorisation of its 3’-SL ingredient in China
  3. Niagen Bioscience secures US patent for NR IV and injectable formulations The company has been granted a US Patent covering intravenous and injectable formulations of nicotinamide riboside (Niagen), strengthening its position in the fast-growing NAD+-boosting clinic market
  4. Gain insight into skin ageing mechanisms driving nutraceutical innovation Exploring the science of skin ageing through a nutraceutical lens at the Anti-Ageing Skin Care Conference
  5. SEPITONE™ : the new secret to youthful radiance Seppic demonstrated the effectiveness and dual action of its fermented wild bilberry extract on skin aging and complexion in two clinical studies

Upcoming event

Making Nutraceuticals

21–22 April 2026 | Conference/Exhibition | Coventry, UK See all

You may also like

Regulatory

FDA calls public meeting to explore scope of dietary supplement ingredients under DSHEA

The FDA has announced a public meeting on 27 March to gather stakeholder feedback on the definition of dietary ingredient categories, including proteins, enzymes and microbials, as it considers its next regulatory steps
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

EFSA finds sucralose to be safe when used as currently authorised ...

... but cannot the confirm safety of extending its use
Regulatory

FDA to reassess the safety of food preservative BHA

The review will assess whether BHA is safe under its current conditions of use in foods such as meats, crisps and other processed products
Regulatory

EFSA sets provisional safe intake level for CBD novel foods

EFSA has established a provisional safe intake level for cannabidiol in food supplements, while still warning that significant toxicological data gaps remain
Regulatory

Danone expands baby formula recall amid cereulide toxin concerns

Food safety alert deepens as additional Aptamil and Cow & Gate First Infant Milk and Follow-on Milk batches withdrawn from the market
Regulatory

FDA eases “no artificial colours” claims and expands natural food dye options

The FDA has announced a new enforcement approach allowing “no artificial colours” claims for products free from petroleum-based dyes, alongside approving beetroot red and expanded spirulina extract use to support a shift toward naturally derived food colourings
Regulatory

EFSA cereulide toxin risk assessment could lead to more baby formula recalls

The EU body's advice sets new limits for cereulide in infant formula, which could potentially trigger more precautionary recalls
Subscribe now